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Cell fate decisions in many physiological processes, including embryogenesis, stem cell 
niche homeostasis and wound healing, are regulated by secretion of small signaling proteins, 
called cytokines, from source cells to their neighbors or into the environment. Concentration 
level and steepness of the resulting paracrine gradients elicit different cell responses, 
including proliferation, differentiation or chemotaxis. For an in-depth analysis of underlying 
mechanisms, in vitro models are required to mimic in vivo cytokine gradients. We set up a 
microparticle-based system to establish short-range cytokine gradients in a three-
dimensional extracellular matrix context. To provide native binding sites for cytokines, 
agarose microparticles were functionalized with different glycosaminoglycans (GAG). After 
protein was loaded onto microparticles, its slow release was quantified by confocal 
microscopy and fluorescence correlation spectroscopy. Besides the model protein lysozyme, 
SDF-1 was used as a relevant chemokine for hematopoietic stem and progenitor cell (HSPC) 
chemotaxis. For both proteins we found gradients ranging up to 50 µm from the microparticle 
surface and concentrations in the order of nM to pM in dependence on loading concentration 
and affinity modulation by the GAG functionalization. Directed chemotactic migration of cells 
from a hematopoietic cell line (FDCPmix) and primary murine HSPC (Sca-1+ CD150+ CD48-) 
toward the SDF-1-laden microparticles proved functional short-range gradients in a two-
dimensional and three-dimensional setting over time periods of many hours. The approach 













Cytokines and other small soluble mediator molecules play a crucial role in cell-cell 
communication of multicellular biological systems. Both long-range (> 100 µm) and short-
range gradients of these agents facilitate many cellular processes, including chemotaxis and 
differentiation during embryogenesis as well as in diseased or regenerating adult tissues. 
Short-range paracrine interactions between neighboring cells are based on secreted 
cytokines, which are diluted with increasing distance from the source cells, leading to the 
establishment of cytokine gradients. Many cellular processes are not sensitive solely to the 
presence of cytokines, but also to cytokine concentrations or gradients [1,2], so that cell fate 
decisions frequently depend on the distance between source and receiving cell. As already 
mentioned, one obvious example is pattern formation during embryogenesis, exemplified by 
the left-right symmetry created by reaction-diffusion pair Nodal-Lefty [3], or drosophila wing 
patterning by hedgehog (HH) [4] and decaplentaplegic (Dpp) [5]. However, paracrine 
signaling also plays a role during wound healing, where platelet-derived growth factor 
(PDGF) attracts fibroblasts [6] and transforming growth factor-β (TGFβ) induces their 
transformation into tissue-contracting myofibroblasts [7], as well as in tumor 
microenvironments [8] and in the regulation of stem cell niches [9]. In these 
microenvironments stem cell fate is balanced by a multitude of signals including paracrine 
cytokine gradients from neighboring cells [10,11]. Common examples of these functional 
entities are the intestinal crypt [12], the hair follicle [13], drosophila testes [14] and the 
hematopoietic stem cell (HSC) niche in the bone marrow [15,16]. 
A well-known phenomenon of cellular sensitivity toward cytokine gradients is directed 
migration of hematopoietic stem and progenitor cells (HSPC) toward gradients of stromal 
cell-derived factor-1 (SDF-1, also known as CXCL12). This directed movement under the 
influence of chemokines is referred to as chemotaxis. SDF-1 is a chemokine supporting the 
homing of HSPC into the bone marrow niche [17], where they show close localization to 
SDF-1-producing stromal cells [16,18]. SDF-1 acts via the G-protein coupled receptor 
(GPCR) CXC chemokine receptor type 4 (CXCR4) natively expressed on HSPC [19]. 
Recently the receptor CXC chemokine receptor type 7 (CXCR7) was identified as another 
target for SDF-1 [20]. It functions mainly as its scavenger thereby modulating cell’s mobility 
[21]. 
In vivo the presentation, storage and gradient accumulation of many of those cytokines is 
facilitated by glycosaminoglycans (GAG) – an important component of the extracellular 
matrix (ECM) [22,23]. These polysaccharides are bound to proteins and besides hydration, 
their key function is the binding and local concentration of growth factors, cytokines and other 
mediators [23]. Different configurations and different degrees of sulfation determine cytokine 
binding, primarily via the variable density of negatively charged moieties. While hyaluronan 
(HA) is the only non-sulfated GAG, heparan sulfate and heparin belong to the most sulfated 
representatives. Because of this well-documented in vivo function the cytokine-GAG 
interaction has been already used for storage and release systems in vitro [24,25]. 
The high complexity of the in vivo tissue microenvironment and stem cell niches established 
by different cell types, cytokines and the ECM makes analyses and understanding of 
regulatory processes difficult. Hence, appropriate in vitro models are required to mimic 
physiological processes, including cytokine gradients [26]. Such in vitro models permit an in-
depth analysis using a multitude of high-resolution techniques. In this way it is possible to get 
an enhanced understanding of the dynamic processes of disease and tissue development, 
often exceling static endpoint analysis obtained from in vivo experiments [27]. Additionally 
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such biomimetic in vitro models can reduce the number of ethically controversial animal 
experiments necessary. Several approaches exist for the formation of in vitro cytokine 
gradients. These include traditional methods like transwell assays (based on Boyden 
chamber) [28], which suffer the disadvantages of ill-defined gradients, endpoint analysis and 
whole cell population based read-outs. Other approaches use microfluidics to achieve 
mediator gradients, which can be precisely controlled and enable accurate prediction of a 
steady-state gradient [29]. However, these methods are frequently limited to long-range 
gradients over several hundred micrometers [30] and are not suited for mimicking short-
range paracrine signals. Furthermore, they are technologically demanding and difficult to set 
up for multipole, complex spatial arrangements. 
We aimed to set up a system to deliver short-range gradients of various mediators in 
different in vitro cell culture environments. The aim was to enable control over cytokine 
gradients at the cellular scale over several days to investigate cellular processes like 
migration, proliferation and differentiation. Moreover, the characteristics of the ECM 
microenvironment should also be controlled in order to better mimic physiological situations 
of stem cell niches, wound healing or tumor progression. We envisioned an arrangement as 
depicted in Figure 1 with protein-laden microbeads (µ-beads) as surrogates for cytokine 
releasing cells and surrounding cells as the receiver of the paracrine signals of interest. Cells 
and µ-beads are embedded in suitable biomimetic ECM matrices, such as functional three-
dimensional (3D) collagen networks as recently introduced [31–33]. Similar µ-beads have 
already been used as single point sources for proteins, based on either surface-bound [34] or 
soluble cytokines [6,35,36]. Exemplarily, such a setup should simulate the HSC bone marrow 
niche with the µ-beads acting as niche cell surrogates in a structured ECM environment 
similar to that occurring in vivo.  
 
 
Figure 1: Setup of short-range cytokine gradients from µ-beads to study paracrine cell signals. 
Protein-laden µ-beads (green) as a local protein delivery vehicle establish short-range, cell-sized 
protein gradients (pale green) in their proximity due to a slow protein release. Cells (red) and µ-beads 
are embedded inside a 3D biomimetic ECM network (black lines). Cells in close proximity are able to 
polarize, migrate, proliferate or differentiate in response to the cytokine gradient. If cells reside far 
away from the µ-beads and thereby outside the gradient, they will not response (round shape). 
 
Our short-range gradient system was realized by usage of cell-sized spherical agarose µ-
beads with different GAG functionalization to control cytokine release. Uptake and release 
kinetics as well as gradient buildup were quantified from observing fluorescently labeled 
model proteins including lysozyme and SDF-1 using confocal laser scanning microscopy 
(cLSM) and fluorescence correlation spectroscopy (FCS). Finally, cell experiments using a 
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hematopoietic cell line and primary murine hematopoietic stem and progenitor cells (HSPC) 
proved the presence of functional short-range cytokine gradients by chemotaxis toward 
SDF-1-laden µ-beads. 
 
Material & methods 
Chemicals 
Cell culture grade phosphate buffered saline (PBS) was purchased from Biochrom (Berlin, 
Germany). Bovine serum albumin (BSA, >98 %, MW = 66 kDa, heat shock fraction), heparin 
(sodium salt from the porcine intestinal mucosa), lysozyme from chicken hen egg white 
(>90 %, MW = 14.3 kDa), monosodium phosphate monobasic monohydrate (NaH2PO4∙H2O, 
BioXtra), sodium phosphate dibasic (Na2HPO4, BioXtra), N-(3-dimethylaminopropyl)-N'-
ethylcarbodiimide (EDC), N-hydroxysuccinimide (NHS) were all purchased from Sigma-
Aldrich (Steinheim, Germany). Sodium bicarbonate (NaHCO3) was purchased from VWR 
(Darmstadt, Germany), sodium azide (NaN3, pure), sodium chloride (NaCl, pure) from 
AppliChem (Darmstadt, Germany), EDC for µ-bead modification from Merck Chemicals 
(Darmstadt, Germany), rat tail collagen I (4.1 mg/ml, 3298599) from Corning (Amsterdam, 
Netherlands), and heparin-FITC from Invitrogen (Darmstadt, Germany). All chemicals were 
used without further purification. Solutions were prepared with deionized water 
(ρ = 18.2 MΩ). 
For µ-bead modification different GAG were used, see also summary in Table 1. Native high 
molecular weight HA (from Streptococcus, average molecular weight as determined with 
laser light scattering Mw = 1.1∙106 g/mol, polydispersity index PD = 4.8) was obtained from 
Aqua Biochem (Dessau, Germany), sulfur trioxide/dimethylformamide complex (SO3-DMF, 
purum, ³ 97%, active SO3 ³ 48%) from Fluka Chemie (Buchs, Switzerland). Fluorescence 
marker (ATTO 565-NH2) was purchased from ATTO-TEC (Siegen, Germany). 
The high-sulfated (hsHA) and the medium-sulfated (msHA) HA derivatives were synthesized 
and characterized as described previously [37]. Low molecular weight HA was prepared by 
ozonolysis of high molecular weight native HA. A 1% aqueous solution of high molecular 
weight HA was treated with ozone, prepared with an ozone generator COM-AD-02 
(ANSEROS Klaus Nonnenmacher, Tübingen, Germany) for 2 h. The ozone concentration 
amounted to approx. 30 g/m3 and a flow rate of 20 to 30 l/h was used. Finally, N2 was passed 
through the solution for 30 min to expel free ozone. The remaining clear solution was 
dialyzed against distilled water, lyophilized and dried under vacuum. The HA was obtained 
with 75 to 85% yield. Analytical data of the HA derivatives (HA, hsHA, msHA) are 
summarized in Table 1. 
The functionalization of the HA derivatives (HA, hsHA) with fluorescence dye 
(ATTO 565-NH2) was carried out at the reducing end-group of the macromolecules as 
previously described [38,39]: Briefly, 0.5 mmol of HA and 0.25 mmol of hsHA, respectively, 
were dissolved in 30 ml of distilled water and the pH value was adjusted with 0.1 M NaOH 
between 7.5 and 8. Then, 500 µg (0.6 µmol) of the fluorescence marker, dissolved in water, 
were added to the solution and the reaction mixture was stirred at room temperature (RT) for 
6 h. After this time, the pH of the mixtures was adjusted to 7.5 and an equimolar amount of 
NaCNBH3 (related to GAG) was added in two portions. After stirring at RT for 3 days, the 
reaction mixture was first dialyzed against deionized water at a pH between 8 and 8.5 and 
afterwards dialysis was continued against deionized water at pH 5.5 to remove residual 
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unbound dye. After filtration, lyophilization and drying in vacuum, the labeled GAG were 
obtained with 85% yield. The msHA was labeled with Atto-565-NH2 attaching the dye 
molecules to the carboxylic functions along the polymer chain. A conventional EDC/NHS 
(Sigma-Aldrich) coupling protocol was used as follows: 0.3 mmol EDC were added to 30 ml 
of a 10 mM aqueous solution of msHA with a pH of about 4.75. Subsequently, 0.3 mmol NHS 
were added and the mixture was stirred for 30 min at RT. Then 0.6 µmol of ATTO 565-NH2, 
dissolved in water, were added to the polymer mixture and stirred at RT for 6 h. The 
remaining free carboxyl groups were saturated using ammonia and the solution was stirred 
for 1 h. After purification as described above the labeled GAG was obtained in 80% yield. 
Non-labeled SDF-1 was purchased from Sigma-Aldrich for the 2D cell culture experiments. 
For the 3D cell culture experiments and protein release analysis, SDF-1 was synthesized by 
solid phase peptide synthesis as previously described [40]. Fluorescently labeled SDF-1 was 
synthesized and labeled with the cyanine-based fluorescent label Chromeo 642 (Sigma-
Aldrich) specifically attached to alkyne-modified lysine residue (K56) of SDF-1 via copper 
catalyzed click-chemistry as described in detail elsewhere [41]. The K56 does not take part in 
cell receptor or heparin binding as shown previously for different modifications at position 56 
[40,42]. 
Fibronectin was isolated from adult human blood plasma following the protocol adapted from 
[43,44]. 
 
Table 1: Properties of the different GAG used for µ-bead modification. Mw was determined by 
laser light scattering (HA, msHA, hsHA) or taken from the manufacturer (heparin). Degree of sulfation 
(D. S.) was determined by elemental analysis [37] or taken from literature (heparin, [45]). 
GAG Mw / kDa D. S. approx. Mw per dimer / Da 
HA 23.0 0 400 
heparin 18.0 2-3 600 
hsHA 21.4 3.8 790 
msHA 23.9 2.3 640 
 
 
Biofunctionalization of microbeads 
The cross-linked aminoethyl-modified agarose µ-beads (4% agarose, mean diameter 17 µm, 
ABT, Madrid, Spain) were modified with the GAG via their carboxyl groups using EDC 
(Merck) according to the manufacturer’s instructions. Briefly, 200 µl of the supplied µ-bead 
suspension were washed three times with water alternated with centrifugation. The 
respective GAG (heparin, HA, msHA or hsHA, for details see Table 1) was dissolved in the 
water suspension at a concentration of 3 g/l and EDC was added at a concentration of 20 g/l 
(0.10 M). The GAG was covalently linked to the µ-beads under constant agitation with an 
orbital shaker at RT for 4 h. The suspension was then washed with water and subsequently 
with 1 M sodium chloride (NaCl) to release electrostatically bound GAG, before washing 
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once more with water. It was finally stored in PBS (150 mM total salt concentration, 12 mM 
buffer strength) containing 0.02% sodium azide (NaN3) as preservative at 4 °C. For analyzing 
the distribution of bound GAG, we used fluorescently labeled derivatives of the respective 
GAG. 
 
Fluorescent labeling of lysozyme 
The fluorescent dye DY-490 (Dyomics, Jena, Germany) and carboxy-tetramethylrhodamine 
(TAMRA, Biotium, Hayward, USA) were supplied as amine-reactive NHS-esters. The 
negatively charged fluorescent dye (DY-490) was used because of its high hydrophilicity and 
low tendency to self-aggregate. However, limited side effects cannot be entirely excluded as 
the coupling of the negatively charged dye to lysine residues reduces the overall positive net 
charge of lysozyme. TAMRA was used for control experiments only. Lysozyme was labeled 
according to the manufacturer's instructions. Briefly, lysozyme was dissolved in PBS and the 
pH of the solution was adjusted to > 8 using bicarbonate buffer (NaHCO3). The final 
lysozyme concentration was about 5 mg/ml. The fluorescent dye was dissolved in water-free 
DMF, immediately before adding it to the protein solution. After a reaction time of around 2 h 
at RT the solution was fractionated using size exclusion chromatography columns 
(Sephadex, GE Healthcare). The fractions containing the protein-dye conjugate were pooled 
and analyzed to determine the protein concentration and degree of labeling using UV/Vis 
spectrometry (Biophotometer, Eppendorf, Germany). 
 
Bead loading and image acquisition 
GAG-functionalized agarose µ-beads were incubated in protein solution with different loading 
concentrations ranging between 100 and 1000 µg/ml at 4 °C for up to 7 d. In order to 
measure protein release we used inverted cLSM (LSM 700 or LSM 780, Carl Zeiss, Jena, 
Germany). To ensure comparability between measurements done on different days, the 
microscope was switched on at least 4 h before measuring. For measurements, 2∙104 µ-
beads were removed from incubation solution, washed three times in PBS alternated with 
centrifugation to remove unbound protein and discard it with the supernatant. Afterwards µ-
beads were poured into a home-made chamber with glass bottom (#1.5 cover slip, Carl 
Zeiss) in 1% BSA (Sigma-Aldrich) in PBS to imitate cell culture media conditions. The 
measurement was started with acquisition of images of the same bead population at time 
points at 0 h, 24 h and 48 h and additional time points up to 8 d. Between time points the µ-
beads were stored at 37 °C to simulate cell culture conditions. We used water immersion 
objectives (40x/1.2 C-Apochromat or 63x/1.3 LCI-Plan Neofluar, Carl Zeiss) together with 
highly corrected cover glasses (# 1.5, deviation ± 5 µm) to decrease optical aberrations. Low 
laser powers (< 2% of a 10 mW diode pumped solid-state laser) were applied to minimize 
bleaching in combination with a low gain and low resolution to achieve ‘spatial binning’, 
thereby increasing signal-to-noise ratio. Field illumination was kept homogeneous to ensure 
constant intensity of excitation light, regardless of the position of the µ-beads in the field of 
view. 
The mean fluorescence intensity (MFI) of single µ-beads was analyzed with FIJI (NIH, USA). 
A binary mask of the µ-bead was created by thresholding (Otsu algorithm) and the MFI of the 
µ-bead was analyzed using the mask area. Using calibration measurements with protein 
solutions of known concentration, the MFI was converted into protein concentration. For 
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some conditions we had to linearly extrapolate calibration curves to higher concentrations 
because of protein accumulation inside the µ-beads relative to loading concentrations. This is 
justifiable as the density of fluorescence label was well below quenching conditions. For each 
time point 30 to 200 µ-beads (20 images respectively) were analyzed, depending on µ-bead 
density in the images. The mean of the measured protein concentrations inside each µ-bead 
was calculated and plotted against the respective time point to yield a release curve. 
 
Theoretical description of protein release and gradient buildup 
The obtained time-dependent release data can be described by a diffusion-based approach 
derived from Fick’s second law [46]. A spherical µ-bead’s radial symmetry leads to eq. (1) 













With boundary conditions of (i) homogeneous initial (t = 0) concentration c0 inside the bead of 
radius a and (ii) negligible concentration increase far away from the µ-bead (considered as 
infinite sink) for t ≥ 0, the solution of eq. (1) for the concentration c in the center of the µ-bead 
















With this equation (n ≤ 7) the cytokine diffusion coefficient inside the µ-bead (DBead) can be 
fitted to the measured release curves as a measure of protein mobility inside the µ-beads. 
The goodness of fit was assessed by coefficient of determination r2 exceeding 0.8. 
A quasi-stationary concentration gradient outside the µ-bead was calculated in a 2D and 3D 
configuration based on Fick’s first law, see [6,46]. We assume (i) an almost constant protein 
release through the surface of the spherical µ-bead (over short time periods, see results), (ii) 
a fast buildup of quasi-stationary conditions and (iii) negligible protein accumulation outside 
the µ-bead in the large cell culture volume. The latter two assumptions are based on the 
difference in mobility inside and outside the µ-beads, indicated by the cytokine diffusion 
coefficient inside the µ-bead (DBead » 0.1 µm2/s, see Results and Discussion) and outside the 
µ-bead (DSolution » 100 µm2/s). With these assumptions the concentration gradient around the 











This equation links local protein concentration cGradient(r) around a spherical µ-bead of radius 
a to the release rate of protein from the µ-bead Dc/Dt, which is treated as roughly constant for 
short time intervals. The release rate is numerically derived from the 1st derivative (slope) of 
the fit of eq. (2) to the release data at the indicated time point. In a 2D case of protein release 
from a µ-bead lying on a substrate surface, eq. (3) has to be multiplied by factor of 2 due to 




Fluorescence correlation spectroscopy  
Release of fluorescently labeled lysozyme was quantified in the vicinity of the µ-beads using 
fluorescence correlation spectroscopy (FCS) at room temperature. µ-beads were loaded with 
DY-490-labeled lysozyme at a concentration of 1 mg/ml for one week as described above. 
After three washing steps with PBS the µ-beads were stored in PBS with 1% BSA and 
released protein for 24 h. Subsequently the µ-beads were washed again three times with 
PBS and placed inside the custom-built measuring chamber. Using this experimental setup 
we determined local concentrations corresponding to protein release rate from the µ-beads 
after 24 h. The fluctuation over time of fluorescence intensity (ten times for 10 s per position) 
was recorded at several positions with defined distance to the µ-bead surface up to a 
distance of 50 µm. The autocorrelation function G(τ) was determined for τ between 0.2 µs 
and 3.35 s. Fitting eq. (4) to the autocorrelation function (for τ > 1.2 µs to exclude detector 
after-pulsing), the molecule number N inside the confocal volume and diffusion time τD can 
























This approach also accounts for triplet state formation with triplet fraction T (< 0.2) and 
typical triplet time τT (1 to 10 µs). The size of the confocal spot, described by the ratio γ = 
z0/ω0 (herein fixed at 6) with the lateral diameter ω0 and the axial diameter z0, was 
determined by FCS analysis of τD of a free dye (Atto-488, Atto-Tec) with known diffusion 
coefficient DDye (400 µm2/s) [49] using eq. (5). 
𝜔. = `4𝐷:b8𝜏\ (5) 
Using Atto-488 as calibration standard, we determined τD between 22 and 25 µs, correlating 
to ω0 of 0.2 µm. 
The diffusion coefficient D (eq. (5)) and the concentration c (=N/V) of the lysozyme-dye 
conjugate was calculated using eq. (5) and (6). For calculating the confocal volume (eq. (6)), 
it is assumed to be of ellipsoidal shape and was determined to be about 0.2 fl. 
𝑉 = 𝜋F/)𝛾𝜔F (6) 
 
Cell experiments 
The FDCPmix cell line was used because of its known chemotactic response to SDF-1 via 
the CXCR4 receptor [50]. FDCPmix (A4) cells were cultured in maintenance medium [51] 
based on Iscove`s Modified Dulbecco’s Medium (IMDM, Biochrom) with osmolarity adjusted 
to 0.32 osm/l and supplemented with 5 mM glucose, 2 mM glutamine, 20% donor horse 
serum and 10% IL-3 conditioned medium [52]. Cells were passaged every two days to a 
density of 5∙105 cells/ml. All cells were cultured at 37 °C in 5% CO2 in air at 95% humidity. 
Primary HSPC derived from murine bone marrow were used as an additional model of 
CXCR4-positive cells. Cells were collected from bone marrow based on SLAM markers 
according to [27]. Briefly, 1-2 mice (C57/Bl6, 8 weeks old) were killed, femurs and tibias 
removed, cleaned free of soft tissue, and crushed with a mortar and pestle. The cell 
suspension in PBS was then filtered and lineage depletion (CD5, CD45R (B220), CD11b, 
Anti-Gr-1 (Ly-6G/C), 7-4, Ter-119) was performed by magnetic sorting (MACS, Miltenyi, 
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Bergisch Gladbach, Germany). Staining of Sca-1 (PE) was complemented by anti-CD150 
(APC) and anti-CD48 (PerCP/Cy5.5) (all BioLegend, Fell, Germany) staining. Dead cells 
were identified by propidium iodide (PI, Sigma-Aldrich) staining. Cells were sorted by flow 
cytometry (FACSAria, BD Biosciences, USA), gating on live, Sca-1+ and refining for CD150+ 
and CD48- to select the long-term repopulating HSPC fraction. After cell sorting HSPC were 
cultured in StemSpan SCFM (StemCell Technology, Cologne, Germany) supplemented with 
10 ng/ml SCF, 10 ng/ml TPO, 20 ng/ml IGF-2, 20 ng/ml FGF-1 (all R&D Systems, 
Minneapolis, USA), 10 µg/ml heparin (5 kU/ml) and 1% penicillin/streptomycin (both from 
Biochrom). 
Two substrate setups were used to follow chemotaxis of cells. The home-made chamber was 
either filled with a 3D collagen network or coated with fibronectin on the cover slip base 
(50 µg/ml in PBS incubated at 37 °C for 1 h). 3D collagen networks were reconstituted 
according to a recently published protocol [32], using phosphate buffer at pH 8 and collagen I 
at a concentration of 3 mg/ml to achieve small pore sizes (4 to 10 µm). These networks 
prevent cells from migrating too fast through the porous network. The µ-beads were 
incubated in SDF-1 solution at a loading concentration of 10 µg/ml over 2 d. They were 
washed three times in PBS and put either into the 3D collagen networks during reconstitution 
or onto the fibronectin-coated surfaces. For control experiments µ-beads without SDF-1 
incubation were used. 
Cells at a density of 2∙104 cells/ml were plated onto fibronectin-coated surfaces or on 3D 
collagen networks. Live cell video microscopy was performed under standard culture 
conditions (37 °C, 5% CO2) with a dry objective (20x/0.35 LD A-Plan for 2D experiments or 
10x/0.3 EC Plan-Neofluar in combination with 1.6x optovar (all Carl Zeiss) for 3D 
experiments) over several hours to days (see Results and Discussion). Control experiments 
were performed under the same conditions using empty µ-beads. For FDCPmix cells on 
fibronectin-coated surfaces, cells around the µ-beads were counted radially using ImageJ 
cell counter in FIJI and distance-dependent cell density was calculated by dividing cell 
number by area of the respective annulus. The cell tracks in 3D experiments were 
determined manually. 
 
Results and Discussion 
µ-bead functionalization with GAG 
We aimed to mimic protein secreting cells via functionalized cell-sized µ-beads. It is 
necessary that these beads store and subsequently release cytokines over prolonged 
periods of time in the order of days. To this end, we utilized native ligands of cytokines in the 
in vivo ECM, namely GAG with different degrees of sulfation in order to adjust cytokine 
affinity. The linkage of GAG to the aminoethyl-functionalized agarose µ-beads was achieved 
by EDC-mediated covalent bond formation between the activated acid groups of the GAG 
(GAG-COOH) and the aminoethyl groups of the agarose µ-beads (agarose-CH2-CH2-NH2) as 
sketched in Figure 2A. Due to the porous inner structure of the crosslinked agarose µ-beads, 
the GAG modification is not restricted to the outer µ-bead region. Images by cLSM, taken at 
the equatorial plane of the µ-beads with a heparin-FITC functionalization, confirmed the 
homogeneous heparin distribution inside the bead (Figure 2C). The variations in intensity are 
due to the porous inner structure of the agarose network. Even after long-term storage (up to 
one year) at 4 °C we were able to detect a similar amount of fluorescence intensity (data not 
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shown), indicating stable covalent bond formation, which is consistent with reports available 
in the literature [53] and from the bead manufacturer (personal communication). 
 
 
Figure 2: Covalent coupling of GAG to agarose µ-beads. A) The covalent amide bond (red) is 
formed between the acidic groups of the GAG (orange, here HA) and the amine groups of the agarose 
(black). B) Post-synthetic modification of commercially derived porous agarose µ-beads comprises 
covalent linkage of GAG (orange) and subsequent cytokine (green) binding due to electrostatic 
interactions. C) Confocal slice through the equatorial plane of a heparin-FITC functionalized agarose 
µ-bead (left) and of a lysozyme-DY-490 laden µ-bead (right, scale bar: 10 µm). D) Structure of a 
heparin dimer, which consists of 2-O sulfated iduronic acid and 6-O,N-sulfated glucosamine. E) 
Dimeric structure of hyaluronic acid (HA) and its chemically sulfated derivatives, consisting of 
glucuronic acid and N-acetylglucosamin. For the completely non-sulfated HA the abbreviation R 
corresponds to a single hydrogen atom. For medium sulfated HA (msHA) and highly sulfated HA 
(hsHA) 2 R or every R represent a sulfate group, respectively, giving for hsHA a charge density even 
higher than that of heparin. 
 
After covalent attachment of the GAG, the system is ready for cytokine loading. The 
dissociation constant Kd of cytokine and GAG as well as the mobility of the cytokine inside 
the bead pores control cytokine release. The simplified overall reaction scheme is illustrated 
in Figure 2B: the affinity-based release system contains 3 major components, (i) the inert 
carrier consisting of crosslinked agarose, with the latter determining the porous structure of 
the delivery vehicle, (ii) a covalently attached GAG, which provides natural binding sites and 
determines the affinity for (iii) particular cytokines, chosen to be relevant for the cell system 
of interest. In contrast to other bead-based release systems made from alginate [35] and 
sulfated alginate [54], we utilized naturally occurring ligands of the cytokines in the ECM. 
Non-sulfated and differentially sulfated GAG were applied, as the degree of sulfation is 
expected to influence cytokine affinity. Using cLSM and fluorimetry in combination with 
fluorescently labeled derivatives, all GAG species used were shown to bind in a similar 
manner and density to the agarose µ-beads using EDC chemistry, see e. g. Figure 2C. 
Heparin usually carries two to three sulfate groups per dimer (Figure 2D) and is the GAG 
with the highest degree of naturally occurring sulfation. Many cytokines are known to bear 
heparin binding sites [22,45], so that heparin has an enormous potential to bind cytokines 
with high affinity. For affinity modulation, chemically modified derivatives of the HA (Figure 
2E) were used. The naturally occurring non-sulfated HA provides only weak attraction, while 
increasing the number of sulfate groups is expected to raise the cytokine affinity accordingly. 
By modulating the cytokine-GAG affinity, we aimed to alter the initial concentration of 
cytokine inside the loaded µ-beads as well as the release kinetics. 
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Modulated release from µ-beads by altered affinity and loading concentration 
In a proof of principle release experiment we used fluorescently labeled lysozyme as a model 
protein because of its high availability, similar size (14.3 kDa) [55] to many cytokines and its 
net positive charge (pI = 11.35) [56], which is also comparable to many cytokines. We 
functionalized µ-beads with different GAG (HA, msHA, hsHA, heparin, see Table 1) to 
modulate protein affinity. Incubation with a lysozyme solution of 1 mg/ml was performed at 
4 °C for one week, achieving reproducible loading results after this incubation time (data not 
shown). The long loading time was used to enable nearly equilibrated protein binding to GAG 
binding sites. Our results (Figure 3A) support the two main hypotheses, that the system 
employed enables (i) a slow lysozyme release over a period of days and (ii) a release 
modulation through GAG-functionalization. All sulfated GAG (heparin, hsHA, msHA) allow for 
high initial loading of the µ-beads in the range of 1 to 2 mg/ml. After a fast drop in lysozyme 
concentration inside the µ-beads during the first 24 h, a small but sustained release is 
observed over several days. This release behavior can be described by the diffusion model 
depicted in eq. (2). A fit of the model to the data reveals a diffusion coefficient inside the µ-
beads DBead of roughly 4´10-5 µm2/s ( 
Table 2). This diffusion coefficient is six orders of magnitude smaller than D for free diffusion 
of lysozyme, which is about 100 µm2/s [57]. This result justifies the assumption made in our 
diffusion-based release model, namely that of a much lower cytokine mobility inside the µ-
bead in comparison to free diffusion outside the µ-bead. 
 




in 10-5 µm2/s 
(mean ± SEM) 
Δc/Δt  after 24 h 
in ng/(ml∙s) 
HA 0.6 ---* ---* 
Heparin 1.3 4.1 ± 0.8 1.3 
hsHA 1.6 4.2 ± 1.1 1.5 
msHA 1.8 3.7 ± 1.0 1.2 
SEM – standard error of the mean. * no significant release detected, therefore not determined. DBead 
and Δc/Δt were determined from fit of eq. (2) to the release data (see Figure 3A), based on at least 
68 individual beads per time point. 
 
The low lysozyme mobility inside the µ-beads suggests the following release mechanisms: 
The crosslinked agarose is considered to be a porous network with negligible influence on 
cytokine mobility due to the very small size (a few nm) of lysozyme in comparison to the 
network pores (150 to 200 nm, according to the bead manufacturer, personal 
communication). The reduction of lysozyme mobility inside the agarose µ-beads is caused by 
the GAG-functionalization, providing highly charged but non-specific binding sites which 
enable continuous re-binding after dissociation. This results in a decreased diffusion 
coefficient determined by the fit (eq. (2)). Hence, inside the µ-bead we have a quasi-static 
equilibrium between a small unbound and a large bound fraction of protein. The unbound 
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protein concentration should drop drastically at the bead surface, because of its release into 
the surrounding medium. The binding and release of protein to and from the GAG is 
influenced by the mutual affinity and the availability of free binding sites, as will be shown 
below. 
The functionalization of µ-beads with HA instead of sulfated GAG showed the modulation of 
loading and release of lysozyme reflecting its affinity for GAG. A much lower initial 
concentration of lysozyme (c0 = 0.6 mg/ml), even smaller than cLoad, and almost no release 
were found for HA functionalization (Figure 3A). A similar dependence on the degree of 
sulfation was recently reported for TGFβ with the highest initial concentration for highly 
sulfated HA [58]. We did not find strong differences in lysozyme mobility (DBead) or release 
rates after 24 h and 72 h dependent on GAG-functionalization. Presumably this behavior is 
caused by similar release mechanisms for all µ-bead modifications, driven by the strong 
concentration gradient at the bead surface. This concentration difference at the µ-bead 
surface is of the same order of magnitude for all experimental settings. For simplification we 
do not consider additional effects due to proteolysis during the time period of the experiment. 
This is reasonable as GAG-facilitated protection from degradation can be assumed for 
proteins in the bound state [23]. In all experiments we find a considerable high fraction of 
immobile lysozyme inside the µ-beads (> 50% of c0) which we attribute to strong electrostatic 
interactions between negatively charged GAG and positively charged lysozyme, usually 
observed in these release systems [24,35]. GAG binding is able to reversibly change protein 
conformation (to maximize free binding enthalpy) [59], but released cytokines keep their 
biological functionality [25,60]. We cannot exclude some irreversible binding events and 
reversible binding with subsequent loss of functionality [61]. However, our functional cell 
experiments shown below demonstrate functional proteins released from the µ-beads over 
long times. 
Cytokine release depends on the affinity to the GAG used for functionalization, but also on 
the loading concentration. Figure 3B shows the dependence of c0 on the loading 
concentration cLoad for hsHA-functionalized µ-beads as an example. In comparison to Figure 
3A the concentration of protein initially bound inside the µ-bead is lower than cLoad due to the 
shortened incubation time of 24 h.  We found an almost linear correlation of c0 and cLoad with 
no saturation even at high cLoad. These results indicate that the GAG-functionalization of the 
agarose µ-beads provides a large number of binding sites for the cytokines that do not 
approach saturation at our loading concentrations. This also supports our proposed release 
mechanism with a quasi-static equilibrium of bound and unbound protein inside the µ-beads 
with many free binding sites available. The similar DBead in the release kinetics independent 
of c0 is also consistent with this idea (data not shown). 
Determination of the very low lysozyme concentration in the surrounding medium around the 
µ-beads was not possible with the cLSM setup, confirming reports by other groups [35]. 
However, the resulting cytokine gradients, which cells are able to detect, can be calculated 
with an analytical solution assuming a nearly constant protein release rate from the µ-bead, 
see eq. (3) in Material and Methods section. This solution holds true for single point sources, 
namely individual and well-separated µ-beads and measurements far away from the µ-bead 
surface, and a low rate of protein release, insufficient to generate considerable increase in 




Figure 3: Modulation of lysozyme release by affinity and loading concentration. A) Lysozyme 
release from GAG-functionalized µ-beads determined over a time period of one week in dependence 
on GAG functionalization. Solid lines correspond to fits of the release data by the diffusion-based 
approach (eq. 2, mean bead radius a = 10 µm). Data are shown as mean ± standard error of the mean 
(SEM). Each data point represents MFI of at least 68 µ-beads. MFI was related to concentration via 
calibration measurements of known lysozyme solutions. The incubation time of µ-beads was 7 d at a 
loading concentration of 1 mg/ml. B) Initial concentration c0 (at t = 0) of lysozyme inside the µ-beads in 
dependence on loading concentration cLoad. Data are shown as described in A) from at least 40 µ-
beads. An incubation time of 24 h was used. C) Expected short-range gradients of lysozyme with 
increasing distance d from µ-beads surface. The concentrations are calculated for indicated bead 
radius a and release rates, depending on the time point of release. The release rates correlate to 
measurements in A) and B). Release rates of 1.2 ng/(ml∙s) and 0.4 ng/(ml∙s) correspond to time points 
24 h and 72 h after start of release, respectively. 
 
We calculated lysozyme gradients using release rates (Dc/Dt) determined from the 
measurements in Figure 3A, see also  
Table 2. The results show that we should be able to construct short-range gradients with 
concentrations of about 50 pM (0.5 ng/ml) at a distance of 50 µm (also depending on the 
mean bead radius a as indicated in Figure 3C). The concentration drops further to 10 pM 
(0.1 ng/ml) over the next 50 µm, farther away from the µ-bead surface. Variation of GAG-
affinity, loading concentration or bead radius allows for the modulation of the release rate 
and the resulting concentration levels of the established gradients. Over longer time periods 
(> 3 days) our system provides constant release rates in the range of 0.4 ng/(ml∙s), which 
correspond to gradients in the lower pM range. As a consequence we expect short-range 
cytokine gradients from 100 pM to 10 pM levels at distances of 10 to 100 µm from the µ-
beads, sufficient for cells to sense [1]. 
 
Experimental verification of short-range protein gradients 
To verify our calculated short-range gradients based on the release data, we utilized 
fluorescence correlation spectroscopy (FCS) to determine the low protein concentration 
directly in the vicinity of the µ-bead. Again, these measurements were carried out using 
fluorescently labeled lysozyme as a model protein. 
We performed single point FCS measurements at different positions with increasing distance 
from the µ-bead surface from 5 µm to 50 µm (Figure 4A). The quantification of lysozyme 
concentration was achieved by means of the autocorrelation curve, derived from the 
temporal intensity fluctuations. At τ = 0 one can extract to number of the fluorescent particles 
inside the confocal volume. An example for an autocorrelation curve at a position 13 µm 
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away from the µ-bead surface is given in Figure 4B. The particle number of N = 0.185 
corresponds to a concentration of 1.5 nM. The respective diffusion time of 65 µs equals a 
diffusion coefficient of 120 µm2/s, which is in accordance with a theoretically obtained and 
experimentally proved diffusion coefficient of lysozyme in solution of around 100 µm2/s [57]. 
As expected the measured local concentrations drop with increasing distance (Figure 4C), 
nicely proving the gradient nature of the protein release. Concentrations next to µ-beads are 
higher and the gradient is stronger than predicted from the steady-state release model 
(eq. (3)). We mainly attribute this to perturbations of FCS measurements in the proximity of 
the highly loaded µ-bead by the high fluorochrome concentrations. Deviations might also 
result from the steady-state solution of protein diffusion not taking into account the details of 
the µ-bead surface crossing. This discrepancy awaits further investigation. At larger 
distances (> 70 µm), no detailed comparison of model and experiment is possible as the 
predicted concentration drops below the quantitation limit of FCS using these settings. 
However, at intermediate distance (15 µm < d < 70 µm) the model predictions of eq. (3) fit 
the experimental data and our cell experiments nicely proof the established gradients (see 
below). 
In summary, these results demonstrate the formation of short-range cytokine gradients in the 
range of 10 to 50 µm, validate their estimation via quantification of protein release from the µ-
beads, and thus advocate the application of this system in cell experiments. 
 
 
Figure 4: Verification of short-range gradients by FCS. A) Example of FCS measurement points 
(crosses) with increasing distance from the bead surface. The bead radius a was 15.5 µm and the 
yellow arrow indicates position of the measuring point for determined autocorrelation function shown in 
B) (scale bar: 20 µm). B) Autocorrelation function G(τ) from position as indicated in A). The red line is 
the resulting fit using eq. 4. The determined number of fluorescent proteins in the confocal volume N 
corresponds to a concentration of 1.5 nM or 22 ng/ml of lysozyme. C) The measurements of local 
concentration at distance d from the µ-bead confirm short-range gradients within a distance of 10 to 
40 µm. The solid line indicates the calculated gradient determined with eq. (3) (2D case) based on the 
experimental release data (here 1.2 ng/(ml∙s)). 
 
Chemotaxis of hematopoietic stem and progenitor cells in local SDF-1 gradients 
After setting up the short-range gradient system using the model protein lysozyme, we chose 
the cytokine SDF-1 as a well-known example to functionally validate our system using 
cultured cells. SDF-1 is a chemokine known to act on the CXCR4 receptor present on HSPC 
and to have an important function in homing of HSPC to the bone marrow niche [17]. With 
 16 
loading and subsequent release of SDF-1 we expect chemotaxis of HSPC toward the µ-
beads, providing a straightforward experimental read-out. 
First we determined the release kinetics of SDF-1 from heparin-functionalized µ-beads. The 
fluorescent label was attached specifically to a non-essential lysine residue (K56) [40–42], so 
that SDF-1-heparin binding can be assumed not to be biased by the fluorescent label. 
Loading concentrations of 10, 20 and 30 µg/ml SDF-1 were chosen according to release data 
from other heparin-based systems available in the literature [25,60]. Our results (Figure 
5A&B) confirm the predictability of our system: (i) high SDF-1 accumulation in the µ-beads 
and (ii) slow release of SDF-1 from the µ-beads, indicating high affinity binding of SDF-1 to 
heparin-functionalized µ-beads. This was to be expected, because of the specific interaction 
of heparin with the respective binding site on SDF-1 [62]. The initial SDF-1 concentration 
inside the µ-beads c0 correlated almost linearly with the loading concentration cLoad as had 
been found for lysozyme (Figure 5C). The fourfold enrichment found comparing cLoad and c0, 
was much higher than that for lysozyme. From the fits of eq. (2) to the SDF-1 release data, 
SDF-1 mobility inside the µ-beads (DBead) was around 8´10-5 µm2/s and therefore in the same 
range as for lysozyme. This finding again supports the idea that cytokine release from the µ-
beads is predominantly influenced by the strong drop in unbound cytokine concentration at 
the µ-bead surface. 
 
 
Figure 5: SDF-1 release from heparin-functionalized µ-beads. A) Release kinetics of SDF-1 from 
µ-beads over several days with different SDF-1 loading concentrations cLoad. Solid lines correspond to 
fits of the release data by the diffusion-based approach (eq. (2), mean bead radius a = 10 µm). Data 
are presented as mean ± standard error (SEM). Each data point represents MFI of at least 30 µ-
beads. MFI was related to SDF-1 concentration via calibration measurements of known SDF-1 
solutions. B) Initial concentration c0 (at t = 0) of SDF-1 inside the µ-beads in dependence on loading 
concentration cLoad from measurements in A). C) Resulting short-range gradient in 3D after 24 h 
around the µ-beads calculated from eq. (3). The release rates (indicated at each line) were taken from 
the fit at 24 h in A), assuming mean bead radius a of 10 µm. D) cLSM image at the equatorial plane of 
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a heparin-functionalized µ-bead illustrates homogeneous initial distribution of fluorescently labeled 
SDF-1 (scale bar: 10 µm). E) A cross-section intensity profile of the µ-bead in D) shows intensity 
maxima at the outer border of the µ-bead. 
 
The observed local accumulation of SDF-1 at the µ-bead surface (Figure 5D&E) probably 
results from the fluorescent dye. Although some reports suggest that this phenomenon can 
be caused by charged molecules (positively-charged SDF-1 entrapped at counter-charged 
pore walls based on negatively-charged heparin [63]), our data indicate a dye artifact. Using 
lysozyme labeled with the hydrophilic DY-490, no protein accumulation was observed at the 
µ-bead surface (see Figure 2C). In contrast, control experiments using a rhodamine-labeled 
(TAMRA) lysozyme showed protein accumulation at the µ-bead surface similar to that seen 
with SDF-1 (data not shown). Hydrophobic interactions at high concentrations between 
rhodamine or cyanine dyes (the latter were used for SDF-1) may therefore explain the 
observed accumulation at the µ-bead surface. 
The experimentally obtained release rates after 24 h (around 5 pg/(ml∙s), depending on the 
loading concentration) were used to determine the SDF-1 gradient in the area surrounding 
the µ-bead based on eq. (3) (Figure 5C). Gradients on a level of 0.1 pM are achieved within 
50 µm distance of the µ-beads, which should be sufficient to provide short-range SDF-1 
gradients to be detected by HSPC. The measured release rates of 5 pg/(ml∙s) 
(corresponding to 10-7 ng/h) are comparable to cell secretion data of SDF-1 (estimated to a 
single cell secretion of about 10-7 ng/h) [64] and to reports of very low SDF-1 release 
(< 10-5 ng/h) from alginate beads [35]. 
Because the level of SDF-1 in the blood stem cell niche is still unknown, cell experiments are 
necessary to clarify whether cells can sense low pM concentrations and respond with 
directed movement toward the chemokine source. However, it is known, that eukaryotic cells 
can sense very shallow gradients to perform chemotaxis [65]. To test our system we used 
FDCPmix cells as a surrogate of HSPC, because they also bear the CXCR4 receptor, 
needed for SDF-1 sensing [50]. As expected SDF-1 laden µ-beads induced chemotaxis 
toward the chemokine source on a fibronectin-coated surface, whereas no directed cell 
movement was observed with the empty µ-beads (Figure 6A). These observations show 
cytokine stability inside the µ-beads and underline the retained biological function after 
chemokine release. We quantified cell density with respect to distance from the µ-bead 
surface for different time points (Figure 6B). The data clearly show the time-dependent 
accumulation of FDCPmix cells next to the µ-beads. This accumulating effect could be 
observed up to a distance of 40 µm away from the µ-bead surface. When we relate this 
distance to our calculated gradients it suggests that FDCPmix cells can sense gradients 
down to a concentration of 2 pg/ml (Δc/Δt ≈ 1 ng/(ml∙s) for these early time points of SDF-1 
release). Hence, these experiments prove the functionality of the established cytokine 
gradients along with their short-range character with some tens of µm range and allow us to 




Figure 6: SDF-1 gradient attracts FDCPmix cells. A) Time series of bright field microscopy images 
of FDCP-Mix cells next to a SDF-1 laden µ-bead (upper row) and an empty bead (bottom row). 
FDCPmix cells only migrate towards the SDF-1 source (scale bar: 40 µm). B) Cell density in 
dependence on distance to µ-bead d at different time points. Cell density was analyzed from time 
series shown in A). The arrow indicates sequential density profiles. 
 
A further test within a cell environment resembling more closely the in vivo situation of the 
bone marrow was performed inside 3D collagen I networks using freshly isolated murine 
HSPC (Sca-1+ Lin- CD150+ CD48-). The SDF-1 laden µ-beads were present during collagen 
network reconstitution and positioned in the lower third of the network layer (approx. total 
thickness 300 µm) due to sedimentation during the reconstitution phase. HSPC were seeded 
on top of the collagen networks. The cells needed around 8 h to reach the µ-bead level. 
Afterwards we investigated the attraction of these cells toward an SDF-1 gradient using video 
microscopy charting the whole 3D collagen network volume. Figure 7 (see also 
supplementary movie S1_HSPC_bead.avi) shows a migrating HSPC that was attracted by 
the SDF-1 gradient. The cell remained within the immediate vicinity (< 50 µm) of the µ-bead 
over 8 h, finally being strongly attracted by the chemokine source. We noted that not all cells 
that reached the bead level migrated toward the µ-beads. This behavior is not unexpected 
due to the short-range character of the gradients and the cell population heterogeneity with 
respect to CXCR4 expression. The latter issue is well-known from other experiments using 
trans-well assays in which only small fractions of the cell population respond to the 
chemokine, irrespective of whether the SDF-1 source is in solution [42] or being released 
from a hydrogel [60]. Furthermore, cells’ indifference toward SDF-1 sources was reported to 
be even more pronounced at low SDF-1 concentrations, comparable to those used in this 
work [42,60]. By comparing our results to theoretically calculated SDF-1 gradients (Figure 
5C) at a distance of 50 µm, we can conclude that at least a subpopulation of HSPC sense 
SDF-1 concentration levels of < 1 pg/ml and respond by migrating towards the source. 
In summary, the experiments using SDF-1 showed that our µ-bead based system delivers 
functional short-range SDF-1 gradients that instruct chemotactic cell migration. Two 
hematopoietic cell types, namely the FDCPmix cell line and primary murine HSPC, showed 
sensitivity for these gradients down to 2 pg/ml or < 1 pg/ml concentrations, respectively, both 
in 2D and 3D cell migration. Further experiments on a single cell level are needed to reveal 




Figure 7: SDF-1 gradient attracts murine HSPC within a 3D collagen network. Time evolution 
(upper part of image) of HSPC migration (arrow) in a 3D collagen I network containing SDF-1 laden µ-
beads (dashed circle). HSPC were initially seeded on top of the network and reached bead level after 
around 8 h. The time series shows HSPC attracted by the short-range SDF-1 gradient (scale bar: 
20 µm). The positions of the cell including the last one in close vicinity of the µ-bead (green) are 




We present a microparticle-based release system to mimic short-range paracrine cell-cell 
interactions. Functionalized and cytokine-laden agarose microparticles were used as 
surrogates of cytokine-releasing cells thereby establishing short-range cytokine gradients 
over a distance of some tens of micrometers. Using GAG as native binding partners of the 
cytokines as well as various cytokine loading concentrations, release rate and concentration 
levels of the cytokine gradients could be adjusted to mimic in vivo situations. A functional 
validation of the system was provided by the chemotaxis of HSPC toward SDF-1-laden 
microparticles. The system offers capability for long-term studies on single cell level in vitro 
and thereby will help to unravel cell fate decisions within heterogeneous cell populations in 
dependence on time and local position within short-range gradients of soluble paracrine 
signals of neighboring cells. 
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